1215291-99-8 Usage
Description
(2R,3R)-3-hydroxy-1,2-Pyrrolidinedicarboxylic acid, 1-(phenylmethyl) ester is a proline derivative with a molecular structure that features a pyrrolidine ring and a phenylmethyl ester group. (2R,3R)-3-hydroxy-1,2-Pyrrolidinedicarboxylic acid, 1-(phenylmethyl) ester has hydroxy and carboxylic acid groups on the pyrrolidine ring, which may contribute to its potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
(2R,3R)-3-hydroxy-1,2-Pyrrolidinedicarboxylic acid, 1-(phenylmethyl) ester is used as a building block for the synthesis of drugs and pharmaceuticals due to its unique structure and the presence of functional groups that can be further modified or utilized in the development of new therapeutic agents.
Used in Organic Chemistry Research:
(2R,3R)-3-hydroxy-1,2-Pyrrolidinedicarboxylic acid, 1-(phenylmethyl) ester is used as a subject of study in organic chemistry to explore its unique structure, reactivity, and potential applications in the synthesis of other organic compounds.
Used in Biochemistry Research:
(2R,3R)-3-hydroxy-1,2-Pyrrolidinedicarboxylic acid, 1-(phenylmethyl) ester is used as a subject of study in biochemistry to investigate its potential biological activity and interactions with biological systems, which may lead to the discovery of new applications in medicine or other biological fields.
Check Digit Verification of cas no
The CAS Registry Mumber 1215291-99-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,5,2,9 and 1 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1215291-99:
(9*1)+(8*2)+(7*1)+(6*5)+(5*2)+(4*9)+(3*1)+(2*9)+(1*9)=138
138 % 10 = 8
So 1215291-99-8 is a valid CAS Registry Number.
1215291-99-8Relevant articles and documents
EP300/CREBBP INHIBITOR
-
Paragraph 0233; 0234; 0268; 0269, (2020/05/30)
The present invention provides a compound having excellent histone acetyltransferase inhibitory activity against EP300 and/or CREBBP, or a pharmacologically acceptable salt thereof. The compound is represented by the following formula (1) or a pharmacologically acceptable salt thereof: wherein ring Q1, ring Q2, R1, R2, R3 and R4 respectively have the same meanings as defined in the specification.
